We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZG icon
2776
Zillow
ZG
$6.3B
$48K ﹤0.01%
1,529
-1,238
-45% -$47.8K
NGVC icon
2777
Vitamin Cottage Natural Grocers
NGVC
$697M
$47.6K ﹤0.01%
1,534
+719
+88% +$20.7K
LINE
2778
Lineage Inc
LINE
$8.09B
$47.6K ﹤0.01%
1,100
-2,408
-69% -$94.7K
BY icon
2779
Byline Bancorp
BY
$1.69B
$47.6K ﹤0.01%
1,263
-354
-22% -$11.9K
EIKN
2780
Eikon Therapeutics
EIKN
$423M
$47.4K ﹤0.01%
3,635
+2,496
+219% +$25.5K
ORN icon
2781
Orion Group Holdings
ORN
$337M
$47.2K ﹤0.01%
2,806
+525
+23% +$7.25K
MUU
2782
Direxion Daily MU Bull 2X ETF
MUU
$4.17B
$47.2K ﹤0.01%
+900
New +$25.6K
ORC
2783
Orchid Island Capital
ORC
$1.12B
$47.1K ﹤0.01%
6,764
-5,841
-46% -$40.3K
TCBX icon
2784
Third Coast Bancshares
TCBX
$715M
$47K ﹤0.01%
1,163
-1,084
-48% -$42.3K
NRIX icon
2785
Nurix Therapeutics
NRIX
$2.39B
$47K ﹤0.01%
1,936
-13,464
-87% -$229K
WEN icon
2786
Wendy's
WEN
$1.22B
$46.9K ﹤0.01%
5,663
-9,426
-62% -$67.4K
CERT icon
2787
Certara
CERT
$1.4B
$46.9K ﹤0.01%
7,165
-269
-4% -$1.52K
RNW icon
2788
ReNew
RNW
$2.5B
$46.9K ﹤0.01%
+7,509
New +$42.3K
DRVN icon
2789
Driven Brands
DRVN
$1.97B
$46.9K ﹤0.01%
3,365
-3,287
-49% -$43.2K
LNC icon
2790
Lincoln National
LNC
$7.89B
$46.8K ﹤0.01%
1,323
-951
-42% -$34.2K
LXRX icon
2791
Lexicon Pharmaceuticals
LXRX
$877M
$46.8K ﹤0.01%
+19,486
New +$38K
UVE icon
2792
Universal Insurance Holdings
UVE
$1.18B
$46.7K ﹤0.01%
1,130
-1,711
-60% -$64.5K
ZVRA icon
2793
Zevra Therapeutics
ZVRA
$657M
$46.6K ﹤0.01%
3,253
-718
-18% -$7.98K
SABR icon
2794
Sabre
SABR
$848M
$46.6K ﹤0.01%
22,319
-1,644
-7% -$2.88K
SIBN icon
2795
SI-BONE Inc
SIBN
$839M
$46.6K ﹤0.01%
2,854
-289
-9% -$4.13K
IBCP icon
2796
Independent Bank Corp
IBCP
$793M
$46.5K ﹤0.01%
1,290
-179
-12% -$6.12K
DCH
2797
Dauch Corp
DCH
$1.24B
$46.5K ﹤0.01%
8,582
-7,205
-46% -$43.8K
FIP icon
2798
FTAI Infrastructure
FIP
$345M
$46.4K ﹤0.01%
10,009
+2,286
+30% +$11.4K
PRTA icon
2799
Prothena Corp
PRTA
$438M
$46.4K ﹤0.01%
4,738
+101
+2% +$997
NPK icon
2800
National Presto Industries
NPK
$1.03B
$46.4K ﹤0.01%
371
-9
-2% -$1.22K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.